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ABSTRACT
We have identified and sequenced a bacteriophage 4105 gene encoding an
immunity repressor, the first to be characterized from a temperate phage
infecting a Gram-positive host. Using superinfection immunity as an assay
for repressor function, the 4105 repressor gene was located within a 740-bp
PvuII-HindIII subfragment near the left end of the )105 EcoRI-F fragment.
We show that the repressor is specified by the 5'-proximal coding sequence
of a translationally overlapping gene pair, transcribed from right to left
on the conventional 4105 map. Comparison of its amino acid sequence (146
residues) with that of a large number of Gram-negative bacterial and phage
repressors revealed a putative DNA-binding region between positions 20 and
39. The coding region is preceded by a strong Shine-Dalgarno sequence
5' AAAGGAG 3'. Deletion analysis of the 5'-flanking DNA allowed to iden-
tify transcriptional control elements. Their structure, 5' TTGTAT 3' at
-35 and 5' TATAAT 3' at -10, strongly suggests that the 4105 repressor gene
is transcribed by the major vegetative form of B. subtilis RNA polymerase,
as would be expected for an early phage gene.
INTRODUCTION
Through the impressive amount of work on the lambdoid coliphages
[reviewed in 1], it is well documented that the lysogenic response to
infection by a temperate phage requires the synthesis of a phage-encoded
repressor. This regulatory protein binds to specific DNA sequences, termed
operators, thereby blocking the expression of lytic genes. As such, the
repressor is also responsible for the immunity of a lysogen to superinfec-
tion by the same or a closely related temperate phage.
The Bacillus subtilis phage 4105 (genome size, 38 kb) most probably
uses a similar pathway for the establishment of lysogeny, but until recent-
ly only little was known on the genetic organization of its immunity re-
gion(s) [2,3]. Combined evidence obtained from the mapping of clear-plaque
deletion mutants [4] and molecular cloning [5,6] suggested that a function-
al 4105 repressor gene is located within the 3.2-kb EcoRI-F fragment (Fig-
ure 1). Recently, we have assigned this repressor gene more precisely to a
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1.1-kb EcoRI-HindIII subfragment at the left extremity of EcoRI-F [7]. We
also identified a repressor-controlled p105 promoter, which was mapped to a
662-bp BclI fragment, partially overlapping the repressor fragment at its
right end [3,7]. Both these elements, repressor and early promoter, were
used in the construction of a thermo-inducible gene expression system for
B. subtilis [7].
Here, we report a detailed analysis, by molecular cloning, DNA se-
quencing and deletion mutagenesis, of this p105 repressor gene and its
flanking regions. We show that the repressor forms part of a pair of
overlapping genes. In addition the amino acid sequence of the 0105 re-
pressor polypeptide was compared to that of other repressors in order to
identify regions possibly involved in DNA-binding.
MATERIALS AND METHODS
Bacterial strains, phage, and plasmids
The following B. subtilis strains were used in this work : B. subtilis
168 (trpC2) and its 4105 wild-type lysogen, and BR151 (trpC2, lys-3,
metB10). These strains, as well as E. coli C600 rk mk, were routinely grown
at 37°C in LB medium supplemented with the appropriate antibiotics. Selec-
tive concentrations were : ampicillin (Ap), 200 pg/ml; erythromycin (Em),
10 pg/ml; kanamycin (Km), 10 pg/ml. Plasmids constructed during this work
are described in the text. They are all derived either from the E. coli
replicon pUC4 (ampicillin-resistant; [8]), or the B. subtilis vectors
pE194cop-6 (erythromycin-resistant; [9]), and pPL703 (kanamycin-resistant;
[10]). Plasmid pCGV14, containing the 2.3-kb PstI fragment I of 4105 [11]
inserted in the PstI site of pE194cop-6, has been described earlier [3].
4105 infectivity assays
These were performed as described [7], using wild-type p105 (109
pfu/ml). Strains scored as immune in this work show at least a 106-fold
reduction in plaque-forming ability compared to sensitive strains.
General recombinant DNA methods
All procedures for plasmid and phage DNA preparation, restriction
ligation, and transformation of competent B. subtilis or E. coli were as
described previously [7].
Nuclease Bal31-induced deletion mutagenesis
Plasmid pCGV14 DNA (Fig. 3A) was linearized with HindIII, phenol-ex-
tracted and ethanol-precipitated, and subjected to Bal31 digestion essen-
tially as described [12,13]. About 8 pg of DNA in 0.1 ml buffer was di-
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gested with 1 unit of Bal3l at 30°C. Fractions were removed after 2.5, 5,
7.5, 12.5, and 15 minutes, and the extent of digestion was monitored by
agarose gel electrophoresis. Subsequently, the appropriate fractions were
pooled, phenol-extracted and ethanol-precipitated, followed by treatment
with the Klenow fragment of DNA polymerase I. The resulting blunt-end
fragments were self-ligated using T4 DNA ligase in the presence of 0.5 mM
spermidine, prior to transformation of B. subtilis BRi51. Individual
erythromycin-resistant transformants were tested for phage ¢105 infec-
tivity, and their plasmid content was analyzed using BclI and PstI diges-
tions to approximately determine the extent of the deletion. Subsequently,
the deletion endpoints in a few of the pCGV14A plasmids (see Results) were
determined at the nucleotide level.
DNA sequencing
Sequences were determined using the Maxam-Gilbert [14] method. Frag-
ments were 5' end-labelled using y-32P-ATP and T4 polynucleotide kinase.
For 3' end-labelling, the Klenow enzyme of DNA polymerase I was used.
RESULTS
The 4105 repressor is encoded by the promoter-proximal of two overlapping
genes
We have previously shown [7] that the left part of 4105 EcoRI fragment
F, more specifically the 1100-bp EcoRI-HindIII subfragment (Figure 1), most
probably encodes a repressor function by virtue of its ability to confer
immunity to 4105 infection when inserted into a B. subtilis cloning vector.
We wanted to determine the nucleotide sequence of this region of the phage
genome. To this end, the 3.2-kb *105 EcoRI-F fragment and the adjacent
0.9-kb EcoRI-H fragment were each cloned in the E. coli replicon pUC4,
yielding respectively plasmids pUC4/F and pUC4/H. A detailed restriction
map of the repressor region, together with the adopted Maxam-Gilbert se-
quencing strategy is shown in Figure 1. Both strands of a 1306-bp segment,
extending from an RsaI site in EcoRI-H to the HindIII site, were completely
sequenced. An additional sequence run, using plasmid pCGV14 DNA, from the
leftmost RsaI site in EcoRI-F to the PstI site in EcoRI-H confirmed the
contiguity of both EcoRI fragments. Within our sequence the position of the
PstI, SstI and NcoI sites is in accordance with the recently reported 4105
restriction map [11]. The sequence was analyzed for open-reading frames
exceeding 300 nucleotides in length. Two partially overlapping open-read-
ing frames were found, designated ORF1 and ORF2 in Figure 1. Both are
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Figure 1. Map position and sequencing strategy of the 4)105 repressor re-
gion.
The top shows a restriction map of a 4)105 DNA segment around 70-75% genome
length, including EcoRI fragments H and F. The location of PstI fragment I
is also indicated. The open bar shows the map position of the repressor
(C(p105). The black bar shows the position of the early promoter BclI
fragment (P). The bottom shows the detailed restriction map of the repres-
sor region. The position and direction of the two ORFs is indicated below
the restriction map. Solid arrows indicate sequences derived by 5' end
labelling. A broken line indicates a sequence generated by 3' end label-
ling. Distances are in bp. El, EcoRI; E2, EcoRII (BstNI); E5, EcoRV; F,
HinfI; H, HindIII; P, PvuII; R, RsaI; 5, Sau3A.
orientated from right to left on the conventional (p105 map. The nucleotide
and deduced amino acid sequences of the ORF1-0RF2 gene pair are shown in
Figure 2. Since ORF2 encompasses the EcoRI site and is thus not entirely
contained within the EcoRI-Hind III fragment, ORFi at this stage seemed to
be the most likely candidate to encode the repressor function. However, the
possibility remained that the C-terminal part of the polypeptide is dis-
pensable for repressor activity, and hence, ORF2 could not yet be definite-
ly excluded.
Figures 1 and 2 show the convenient location of a PvuII site with
respect to the functional separation of both coding sequences this site
is well downstream from the stop codon of ORF1, whereas it occurs within
the 14th codon from the N-terminus of ORF2. Hence, we decided to assay the
740-bp PvuII-HindIII fragment for repressor activity. The B. subtilis
vector pPL7O3 [10] containing unique HindIII and PvuII sites, was digested
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with both enzymes and ligated to HindIII+PvuII-digested pUC4/F. A large
number of kanamycin-resistant B. subtilis transformants were subsequently
tested for sensitivity to 4105. Only those cells containing a recombinant
plasmid (designated pCGV23; see Fig. 3B) in which the 850-bp HindIII-PvuII
vector fragment was substituted by the HindIII-PvuII fragment comprising
ORF1, were found to be immune to p105 superinfection. This finding conclu-
sively demonstrated that ORF1 codes for the repressor.
Immediately preceding ORF1 is a sequence 5' AAAGGAG 3', showing a 7-bp
complementarity to the 3' end of B. subtilis 16S rRNA [15], and hence
representing a strong ribosomal binding site. In view of the frequent use
of initiation codons other than ATG in B. subtilis [16], there are two
possible candidates to serve as translational starts for the repressor :
the GTG codon at position +1, and the in-frame ATG codon at position +10.
We have as yet not been able to discriminate between these two possibili-
ties. The respective distances between these codons and the above-defined
Shine-Dalgarno sequence are 4 and 13 bases, whereas on the average a spac-
ing of 8 to 9 nucleotides is found for B. subtilis genes [16,17]. Thus,
the 4105 repressor monomer either consists of 146 or 143 amino acids, with
calculated molecular weights of 16,745 or 16,387 daltons. These values
correspond to a reasonable extent with the results obtained by examining
the polypeptide synthesis pattern in B. subtilis minicells after infection
with 4105 [18]. One of the earliest polypeptides, whose synthesis was not
inhibited by chloramphenicol treatment, showed an apparent molecular weight
of 18,000 on SDS-acrylamide gel electroforesis, and might therefore repre-
sent the product of this repressor gene.
Translation of ORF2 most probably starts at the ATG codon overlapping
the triplets for residue 142 and 143 of the repressor. The function of the
ORF2 gene product (157 amino acids) is unknown but its expression is ob-
viously coregulated tightly with that of the repressor. This kind of
translational overlap is quite unusual, but by no means unique [19]. In the
case of the overlapping coat and lysis protein genes of RNA coliphages, it
has been proposed that translation of the distal gene depends on a frame-
shift during translation of the proximal gene [20]. We have as yet no
evidence that this might be true also for the repressor-ORF2 genes, but it
is clear that the putative, if any, Shine-Dalgarno site preceding ORF2,
5' AAAGAAA 3', shows less complementarity (5 bp) to the 16S rRNA 3' end
than its repressor counterpart.
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5' Hind III -250 -200
AAGCTTTTTCCCATCCAGCATGATTATCACCTCCCGTTAAGGTATGTCTAAATTGTATGGTATTCACGACATTTT
-150
GTAAAAGTCGAAATTTGACGAAATTCAAGCATTTTAAAGATTCAGAGAGTATTTATCTTGTATTTCCGTCAATTTACTAA
t0.rI00 -50
AAMATACTTGTATTTCCGTCTTTTTTAGTA~ ~TCCGACATTCGGATA A GTGTCATGCCACAAGACACA
A1(.) +1 BclI
GTGGCACAGTGAGGCACTATGTGTTGTAAAGGAGATAG GTG ATC ATA ATG ACT GTA GGG CM AGA ATC
"*5(~)A82(-) fMet Ile Ile Met Thr Val Gly Gln Arg Ile 9A15(-82(-) ORF I1-
AAA GCC ATT AGG MG GM CGT AAA TTA ACC CM GTG CM CTG GCT GM AAA GCC MT CTT
Lys Ala Ile Arg Lys Glu Arg Lys Leu Thr Gln Val Gln Leu Ala Glu Lys Ala Asn Leu 29
100
TCA CGT TCA TAC CTT GCA GAT ATT GM AGA GAT AGA TAC MC CCA AGC CTT TCC ACA TTA
Ser Arg Ser Tyr Leu.Ala AsE Ile Glu Arf Asp Arg Tyr Asn Pro Ser Leu Ser Thr Leu 49
?00
GM GCA GTT GCA GGC GCG TTG GGC ATT CAG GTC TCT GCC ATT GTT GGC GAG GM ACT CTT
Glu Ala Val Ala Gly Ala Leu Gly Ile Gin Val Ser Ala Ile Val Gly Glu Glu Thr Leu 69
ATT AAA GM GAG CAG GCC GM TAT MT TCA AAA GM GAA MG GAC ATT GCA AAA CGT ATG
Ile Lys Glu Glu Gln Ala Glu Tyr Asn Ser Lys Glu Glu Lys Asp Ile Ala Lys Arg Met 89
300
GAG GAA ATA AGA MG GAC TTA GM AAA TCG GAC GGT CTT AGC TTT TCT GGA GAG CCC ATG
Glu Glu Ile Arg Lys Asp Leu Glu Lys Ser Asp Gly Leu Ser Phe Ser Gly Glu Pro Met 109
AGT CAA GM GCT GTT GAG TCT CTC ATG GM GCG ATG GAG CAC ATA GTT CGT CAA ACG CM
Ser Gln Glu Ala Val Glu Ser Leu Met Glu Ala Met Glu His Ile Val Arg Gln Thr Gln 129
/400
AGA ATA MT AAA MG TAC ACT CCA MG AAA TAT AGA MT GAC GAT CM GM TAG G GGG
Arg Ile Asn Lys Lys Tyr Thr Pro Lys Lys Tyr Arg Asn Asp Asp Gln Glu xxx 146
fMet Thr Ile Lys Asn Arg Gly 6
Pvu II ORF 24 500
CCT TAT ACT TTG ATA AAA GCA GCT GTG CM AGA CTA ATT AAA MG TAT AAA ACC AGT MT
Pro Tyr Thr Leu Ile Lys Ala Ala Val Gln Arg Leu Ile Lys Lys Tyr Lys Thr Ser Asn 26
CCT TAT GAG CTT GCA TCA TAC ATA MT ATA MT GTT ATT CCA TGG MC TTG CAT CAT GM
Pro Tyr Glu Leu Ala Ser Tyr Ile Asn Ile Asn Val Ile Pro Trp Asn Leu His His Glu 46
600
ATA ATG GGT TTT TAT MG TAT GAT MG CGA AMT AAA TAT ATC GTT ATC MT TCC MC TTA
Ile Met Gly Phe Tyr Lys Tyr Asp Lys Arg Asn Lys Tyr Ile Val Ile Asn Ser Asn Leu 66
MC CAG GCA GM AGA ACT TTT GTG TGC TCC CAT GM TTA GGG CAT GCA CAG TTA CAC CCA
Asn Gln Ala Glu Arg Thr Phe Val Cys Ser His Glu Leu Gly His Ala Gln Leu His Pro 86
700
CGG GCA MT ACA CCA TTT ATG AAA GAG CGT ACT CTT TTC TCA GTT GAT AAA TAT GAG GTT
Arg Ala Asn Thr Pro Phe Met Lys Glu Arg Thr Leu Phe Ser Val Asp Lys Tyr Glu Val 106
p00
GAG GCA MT ACC TTT GCG GTT GAG CTC CTT CTT CCC GAT TGG GTA GTA AGC CM TAT AAA
Glu Ala Asn Thr Phe Ala Val Glu Leu Leu Leu Pro Asp Trp Val Val Ser Gin Tyr Lys 126
EcoRI PatI
MT ACT GM TTC ACC CTT GAT GAT ATA GCT GTC ATG MT GGG GTT CCT GCA GAG TTA GCC
Asn Thr Glu Phe Thr Leu Asp Asp Ile Ala Val Met Asn Gly Val Pro Ala Glu Leu Ala 146
900
CAC CTA AAA GAC CTA TCA GAG CTA AAA MT TTT TAG CCCGAAAACAGAACATATGTTTCCAAAAAGGG
His Leu Lys Asp Leu Ser Glu Leu Lys Asn Phe xxx 157
1000
AGGATAGATTATCATGMCTTGATGGATGAAAACACTCCAAAGMTGTCGGGATATACGTTAG6GTTTCMCAGMGMC
RsaI
MGCAAAAGMGGGTAC
3'
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Deletion Analysis of the 5' Upstream Control Region of the Repressor-ORF2
Genes
Having defined the structural part of the 4105 repressor gene, we were
next interested in identifying the control signals for the repressor-ORF2
transcription unit in the 5'-flanking DNA. Plasmid pCGV14 (Figure 3A) con-
tains the intact ORF1 with over 1 kb of upstream sequence, and as expected
it confers immunity to 4105 infection [3].
In this plasmid, the HindIII site 272 bp upstream of ORF1 is unique.
To create a series of deletions starting from this site and progressing
towards the beginning of ORF1, HindIII-linearized pCGV14 DNA was treated
with the Bal3l nuclease as described in Materials and Methods.
As a result we obtained a collection of pCGV14 mutants (pCGV14A...)
with deletions extending in both directions from the HindIII site, and
ranging in size from less than 100 to over 2000 bp. In this collection the
two phenotypic classes were represented: some pCGV14A plasmids had retain-
ed the superinfection immunity phenotype of the parent pCGV14 whereas in
the majority it was lost. All plasmids with a deletion extending beyond
the BclI site at the N-terminus of ORF1 fell into the latter category,
indicating that an intact ORF1 is not only sufficient, but also necessary
for superinfection immunity. Moreover, some deletion plasmids, such as
pCGV14A15 and pCGV14A82, still contained this BclI site and yet gave rise
to ¢105-sensitive cells. Sequence analysis (Figure 2) showed that
pCGV14t15 has retained 36 nucleotides upstream of the GTG, and pCGV14A82
ends at -26. The deletion endpoints in two immunity-conferring plasmids,
pCGV14A1 and pCGV14A8, were localized at -109 and -182 respectively. These
results clearly indicate that the region between -109 and -36 upstream from
the GTG is required for the expression of superinfection immunity, even
from a multicopy plasmid. We propose that the promoter for the repressor-
ORF2 transcription unit is contained within this region. Figure 2 shows the
presence of two hexanucleotides, 5' TTGTAT 3' and 5' TATAAT 3' separated by
Figure 2. Nucleotide and deduced amino acid sequences of the 0105 repressor(ORF1)-ORF2 genes and their flanking regions.
The sequence is shown in reversed orientation with respect to Figure 1, in
order to display the sense strand. It extends from the HindIII site 272 bp
upstream of the repressor-coding sequence, to an RsaI site within the 4105
EcoRI-H fragment. Nucleotide numbering starts from the GTG codon (+1).
Amino acids are numbered at the right. The endpoint of the deletions in
four PCGV14A... mutants is indicated. The promoter "-35" and "-10" regions
are boxed, and the Shine-Dalgarno sequence is underlined. The dashed line
in ORF1 indicates a putative DNA-binding region.
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Figure 3.
A. Circular map of plasmid pCGV14 [3].
The orientation of the 4105 PstI-I fragment (thin line) with respect
to pE194cop-6 (thick line) was determined by digestion withRXbaI+PvuII.
The position of ORFJ is indicated by the dashed arrow. Em , erythro-
mycin resistance.
B. Circular map of pCGV23.
This plasmid is derived from pPL703 [10] through substitution of the
850-bp HindIII-PvuII vector fragment Rwith the 740-bp HindIII-PvuII4105 fragment comprising ORF1. Km , kanamycin resistance; cat-86,
a chloramphenicol resistance gene originating from Bacillus pumilus.
exactly 17 bp. In view of the homology between these sequences and the
consensus for a u55-dependent promoter [17], it is likely that these serve
as "-35" and "-10" recognition sites for the major vegetative form of B.
subtilis RNA polymerase. This is consistent with the idea that the repres-
sor is probably one of the first phage genes to be expressed after infec-
tion, and therefore its transcription should rely entirely upon the host
machi nery.
We further note that these promoter elements are preceded by a very
AT-rich region, (76% between positions -150 and -90), a feature common to
several other B. subtilis genes [16,17].
The *105 repressor polypeptide: properties and comparison with known
repressors
The codon usage and amino acid compositions for 4105 repressor and
ORF2, as deduced from the nucleotide sequence, are shown in Table I.
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Table I. Codon usage for the (105 repressor (ORF1) and ORF2 genes
ORF1 ORF2 ORF1 ORF2 ORF1 ORF2 ORF1 ORF2
Phe TTT 1 5 Ser TCT 3 0 Tyr TAT 2 8 Cys TGT 0 0
TTC O 2 TCC 1 2 TAC 3 1 TGC 0 1
Leu TTA 3 4 TCA 3 3 Och TAA 0 0 Umb TGA 0 0
TTG 1 2 TCG 1 0 Amb TAG 1 1 Trp TGG 0 2
Leu CTT 5 5 Pro CCT 0 3 His CAT 0 4 Arg CGT 4 1
CTC 1 1 CCC 1 1 CAC 1 2 CGC 0 0
CTA 0 4 CCA 2 3 Gln CAA 7 2 CGA 0 1
CTG 1 0 CCG 0O CAG 2 2 CGG 0 1
Ile ATT 6 2 Thr ACT 3 4 Asn AAT 4 11 Ser AGT 1 1
ATC 2 3 ACC 1 3 AAC 1 3 AGC 2 1
ATA 4 5 ACA 1 1 Lys AAA 9 9 Arg AGA 6 2
Met ATG 5 4 ACG 1 1 AAG 5 4 AAG 1 1
Val GTT 4 6 Ala GCT 2 2 Asp GAT 3 5 Gly GGT 1 1
GTC 1 2 GCC 4 1 GAC 4 1 GGC 3 0
GTA 1 2 GCA 4 7 Glu GAA 14 4 GGA 1 0
GTG 1 2 GCG 2 1 GAG 6 7 GGG 1 3
Total: 146 157
In what follows, we have tentatively assigned translation initiation
to the GTG codon and assume that the terminal residue of the mature repres-
sor polypeptide is isoleucine (Figure 2). The repressor does not contain
cysteine or tryptophan, but has a high content of glutamic acid (20 resi-
dues). Its pI is likely to be close to neutral, given the sum of acidic
residues (Asp + Glu = 27), and basic residues (Arg + His + Lys = 26). The
most striking overall property of the polypeptide is its pronounced hydro-
philicity, as illustrated in the hydropathy profile (Figure 4). Very
hydrophilic regions extend from residues 10-19, 36-41, 71-100 and 130-146,
whereas the only hydrophobic regions are found between residues 1-5 and
51-64. Clearly, this feature refers to the cytoplasmic localization of the
repressor protein.
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Figure 4. Hydropathy profiles of the p105 repressor, according to the
method of Hopp and Woods [31], solid line, and to that of Kyte
and Doolittle [32], broken line.
Values were obtained using the average of a moving segment of 7 residues.
Hydrophilic regions are found above the midline, hydrophobic are below.
In order to elucidate which region(s) of the polypeptide might be
involved in DNA binding, we carried out an extensive comparison of its
amino acid sequence with that of several other repressors functional in
Gram-negative bacteria such as E. coli or S. typhimurium. These included :
A cI repressor [21,22], A cro protein [23], phage P22 c2 repressor [24],
lac repressor [25], gal repressor [26], and the lexA gene product [27].
The most favorable alignment for each pair of sequences was obtained using
the Needleman-Wunsh algorithm [28], as modified by Kanehisa [29].
Table II summarizes the results for each pairwise comparison. The
overall homology, at the primary structure level, between p105 and any of
the other repressors is insignificant as the highest proportion of iden-
tical residues, obtained with the lexA protein, amounts to less than 18%.
However, figure 5 shows that there may exist some meaningful local homology
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Table II. Comparison of the 4105 repressor amino acid sequence with that
of other repressors
Protein No. of compared Matches %
positions
A cI 146 14 9.6
X cro 65 4 6.2
P22 c2 146 24 16.4
lac R 147 14 9.5
gal R 146 16 11.0
lex R 152 27 17.8
in the N-terminal regions of )105 repressor and phage P22 c2 repressor. On
a total of 57 compared positions, 17 homologies are found without the need
to introduce gaps. This could be relevant in view of our recent finding
that phage 4105 contains two immunity regions [3]. We speculate that this
sequenced gene corresponds to the immC region of phage P22, and that the
other 4105 region (located in the EcoRI-B fragment) is analogous to the
mnt/ant (or immI) region of P22.
A further comparison step was based on the well documented observation
that all known repressors, regardless of the specific operator sequence to
which they bind, contain a stretch of 20 contiguous residues exhibiting an
a-helix - turn - a-helix configuration [30]. This three-dimensional struc-
tural element is essential for interaction with the major groove of the DNA
helix. We examined the 4105 sequence for regions whose sequence would be
compatible, at each crucial position, with the sequences of this DNA-bind-
ing domain in a number of other repressors [30]. As a result we propose the
region extending from position 20 (Gln) to 39 (Arg) as the most likely
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Figure 5. Alignment of the N-terminal amino acid sequences of 4105 repres-
sor (top) and S. typhimurium phage P22 c2 repressor (bottom).
The one-letter notation for amino acids is used. Residue numbers for 4105
repressor are identical to Figure 2. In P22 c2 repressor, the N-terminal
methionine is deformylated, but not removed after translation [23]. Hence,
numbering starts with this residue. Positions showing identical residues
are boxed. Positions with a functionally rather conservative substitution
are indicated by a vertical connector line.
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Helix 2 turn Helix 3
A cI Q S V A D K M G M G Q D G V G A L F M
33 52
A cro Q T K T A K D L G V Y Q S A I N K A I H
16 35
P22 c2 Q A A L G K M V G V S N V A I S Q W E R
21 40
Lac R L Y D V A E Y A G V S Y Q T V S R V V N
6 25
Gal R I K D V A R L A G V S V A T V S R V I N
4 23
Lex R R A E I A S R L G F R S P N A A E E H L
28 47
y6 resolvase A S H I S K T M N I A R S T V Y K V I N
161 180
105 R Q V Q L A E K A N L S R S Y L A D I E R
20 39
Figure 6. Amino acid sequence homologies (one-letter notation) between
several repressors in the region corresponding to the u2-turn-03
configuration of A cI and A cro.
Except for the 4)105 repressor, data have been reproduced from [30]. The
amino acid positions within each individual polypeptide are shown below its
sequence. The crucial positions (residues 5, 9, 15, 18) are boxed.
candidate. In Figure 6 we have aligned this region with that of seven
other repressors. The most important positions are 5, 9, 15 and 18 which
should have alanine, glycine, and two hydrophobic amino acids, respective-
ly. The 0105 sequence conforms well in three of these positions, whereas
in position 9 it has asparagine which is, however, also found at that
position in y6-resolvase. Furthermore, hydrophobic residues should be
present in positions 4, 8, and 19. Our p105 sequence again agrees at two
of these positions (4-Leu and 8-Ala), and the glutamic acid at 19 is also
present in the P22 c2 repressor. Lastly, hydrophilic residues should occupy
positions 1-3, 6-7, 11-14 and 16-17. Again, the 4105 sequence shows hydro-
philic side chains in 9 out of these 11 positions. It is clear, however,
that these arguments should be substantiated by further work, such as the
isolation and mapping of p105 repressor mutants affected in operator bind-
ing.
DISCUSSION
We have presented a detailed characterization of an immunity region of
the B. subtilis temperate phage p105, including the structural gene for the
5452
Nucleic Acids Research
repressor and the region controlling its transcription and translation.
Throughout this work we used immunity to 105 infection as a simple assay
for the repressor function.
We should note, however, that a *105 promoter-operator site controlled
by the repressor has been localized within the 662-bp BclI fragment (Fig-
ure 1) immediately upstream from the repressor coding sequence [7]. This
promoter directs transcription from left to right, and therefore can be
topologically considered the equivalent of X PR with respect to the 4105
repressor. In addition, this promoter has been inserted in front of the
cat-86 gene in plasmid pPGV10 [7]. Using such a hybrid construction, we
were able to assay the repressor function more directly, by testing the
chloramphenicol resistance of B. subtilis [pPGV10] strains transformed
with the different repressor plasmids constructed during this work, such as
pCGV14 and its deletion derivatives. A perfect correlation was found
between the superinfection immunity phenotype and the inhibition of cat-86
expression, resulting in Cm sensitivity of the double transformant. A
+105-sensitive phenotype, on the other hand, was always accompanied by the
restoration of cat-86 expression, giving rise to EmRCmR cells (data not
shown). Hence, we believe that we have characterized a true phage repres-
sor in the full sense of the word, which is functionally analogous to, for
example, the X cI gene product.
There are, however, obvious differences in the organization of the
4105 immunity region compared to that of X or the immC region of phage P22.
First, the ¢105 repressor, unlike its Gram-negative counterparts, forms
part of a translationally overlapping pair of cistrons. The function of
ORF2 as well as the reason why its expression should be coordinated so
tightly with that of the repressor, are intriguing questions for which we
have no answer to date.
Second, preliminary mapping data on the above mentioned target pro-
moter-operator site [Dhaese et al., in preparation] indicate that it is
located to the right of the HindIII site (Figure 1), and hence, at least
272 bp removed from the repressor initiation codon. In X and P22, the
PRR0R signals are immediately adjacent to the repressor coding sequence
[1].
Our results suggest further that the *105 repressor transcript, start-
ing most likely some 10 bp downstream of the "TATAAT" hexanucleotide in
Figure 2, contains at least 50 bases of untranslated leader, including a
strong ribosomal binding site. Again, this is different from X cI whose
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transcription from the PRM promoter, initiates at the ATG codon [33] and
the P22 c2 maintenance RNA which contains only four 5'-untranslated nucleo-
tides [34].
Using a comparative approach, we have tentatively identified a DNA-
binding region within the 4105 repressor polypeptide, extending from resi-
due positions 20 to 39. It is now possible to test this assignment by
targeted mutagenesis of the corresponding DNA sequence.
In conclusion, we believe that this work only constitutes a modest
first approach to unravel the possible intricacies of the genetic organiza-
tion of the *105 immunity system. Two important, unanswered questions are:
(i) what is the number, position and structure of the operator sites; and
(ii) does the 4105 repressor also regulate its own transcription ?
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